Patterson Farms

Maple products

The most important problems of introducing medical combination products to the market

A transdermal patch is a galenic form incorporating a source of active substance that is freed gradually when attached to the skin. Its scope is for the pharmaceutical to get in the systemic circulation through the skin surface and not the drug's activity in the skin itself.


While we age, steadily we add more pharmaceuticals in our every daylives, and for this motive, the patches that stick on the skin get a crucial importance to ward off problems due to a high consumption of pharmaceuticals, especially in the elderly age, and as well for your convenience.


Medicine-device combination inventions, such as transdermal patch, initiated a new activity on medical product improvement, regulatory ratification, and corporate interaction that provide valuable lessons for the improvement of new kinds of combination solutions. Analysis show that the biggest obstacle to introduce a new sort of combination products is the creation of the regulatory center which is to inspect its approval, and also the device contract. The first invention of a new kind of combination product gives a learning opportunity for the regulator and the benefactor. Once that the first product is ratified, the leading regulatory center is determined, and the uncertainty about the entire class of combination products is drastically reduced.




The sponsor developing a new type of combination products embraces a principal role in reducing this uncertainty by recommending the decision on the primary function of the combination product. This decision influences the nature of the companies that will guide the implementation of these inventions into the market.

Posted by Administrator on 2018-06-19 08:39:52